How much do you agree with the following statements? *

	Strongly disagree	Disagree	Slightly disagree	Neither	Slightly agree	Agree	Strongly agree
The activity presented balanced, evidence-based content free of commercial bias.	The activity presented balanced, evidence-based content free of commercial bias. - Strongly disagree	The activity presented balanced, evidence-based content free of commercial bias. - Disagree	The activity presented balanced, evidence-based content free of commercial bias. - Slightly disagree	The activity presented balanced, evidence-based content free of commercial bias. - Neither	The activity presented balanced, evidence-based content free of commercial bias. - Slightly agree	The activity presented balanced, evidence-based content free of commercial bias. - Agree	The activity presented balanced, evidence-based content free of commercial bias. - Strongly agree
The presenter(s) used an effective teaching strategy.	The presenter(s) used an effective teaching strategy. - Strongly disagree	The presenter(s) used an effective teaching strategy. - Disagree	The presenter(s) used an effective teaching strategy. - Slightly disagree	The presenter(s) used an effective teaching strategy. - Neither	The presenter(s) used an effective teaching strategy. - Slightly agree	The presenter(s) used an effective teaching strategy. - Agree	The presenter(s) used an effective teaching strategy. - Strongly agree
The presentation slides / digital materials / resources and handouts were high quality.	The presentation slides / digital materials / resources and handouts were high quality. - Strongly disagree	The presentation slides / digital materials / resources and handouts were high quality. - Disagree	The presentation slides / digital materials / resources and handouts were high quality. - Slightly disagree	The presentation slides / digital materials / resources and handouts were high quality. - Neither	The presentation slides / digital materials / resources and handouts were high quality. - Slightly agree	The presentation slides / digital materials / resources and handouts were high quality. - Agree	The presentation slides / digital materials / resources and handouts were high quality. - Strongly agree
The content was relevant to / useful for my professional practice.	The content was relevant to / useful for my professional practice. - Strongly disagree	The content was relevant to / useful for my professional practice. - Disagree	The content was relevant to / useful for my professional practice. - Slightly disagree	The content was relevant to / useful for my professional practice. - Neither	The content was relevant to / useful for my professional practice. - Slightly agree	The content was relevant to / useful for my professional practice. - Agree	The content was relevant to / useful for my professional practice. - Strongly agree
The activity contributed to my knowledge, skills, and capacity to enhance the delivery of patient care.	The activity contributed to my knowledge, skills, and capacity to enhance the delivery of patient care. - Strongly disagree	The activity contributed to my knowledge, skills, and capacity to enhance the delivery of patient care. - Disagree	The activity contributed to my knowledge, skills, and capacity to enhance the delivery of patient care. - Slightly disagree	The activity contributed to my knowledge, skills, and capacity to enhance the delivery of patient care. - Neither	The activity contributed to my knowledge, skills, and capacity to enhance the delivery of patient care. - Slightly agree	The activity contributed to my knowledge, skills, and capacity to enhance the delivery of patient care. - Agree	The activity contributed to my knowledge, skills, and capacity to enhance the delivery of patient care. - Strongly agree
The overall quality of the educational activity was excellent.	The overall quality of the educational activity was excellent. - Strongly disagree	The overall quality of the educational activity was excellent. - Disagree	The overall quality of the educational activity was excellent. - Slightly disagree	The overall quality of the educational activity was excellent. - Neither	The overall quality of the educational activity was excellent. - Slightly agree	The overall quality of the educational activity was excellent. - Agree	The overall quality of the educational activity was excellent. - Strongly agree

The activity successfully achieved its learning objectives by enhancing my ability to: *

	Strongly disagree	Disagree	Slightly disagree	Neither	Slightly agree	Agree	Strongly agree
Apply DHA-Administrative Instruction (AI) 6025.32 requirements and updated 2025 Centers for Disease Control & Prevention (CDC) Clinical Guidance for PrEP recommendations.	Apply DHA-Administrative Instruction (AI) 6025.32 requirements and updated 2025 Centers for Disease Control & Prevention (CDC) Clinical Guidance for PrEP recommendations. - Strongly disagree	Apply DHA-Administrative Instruction (AI) 6025.32 requirements and updated 2025 Centers for Disease Control & Prevention (CDC) Clinical Guidance for PrEP recommendations. - Disagree	Apply DHA-Administrative Instruction (AI) 6025.32 requirements and updated 2025 Centers for Disease Control & Prevention (CDC) Clinical Guidance for PrEP recommendations. - Slightly disagree	Apply DHA-Administrative Instruction (AI) 6025.32 requirements and updated 2025 Centers for Disease Control & Prevention (CDC) Clinical Guidance for PrEP recommendations. - Neither	Apply DHA-Administrative Instruction (AI) 6025.32 requirements and updated 2025 Centers for Disease Control & Prevention (CDC) Clinical Guidance for PrEP recommendations. - Slightly agree	Apply DHA-Administrative Instruction (AI) 6025.32 requirements and updated 2025 Centers for Disease Control & Prevention (CDC) Clinical Guidance for PrEP recommendations. - Agree	Apply DHA-Administrative Instruction (AI) 6025.32 requirements and updated 2025 Centers for Disease Control & Prevention (CDC) Clinical Guidance for PrEP recommendations. - Strongly agree
Outline how to prescribe medication regimens that are proven safe and effective for HIV-negative patients who meet recommended screening criteria for PrEP initiation to reduce their risk of HIV acquisition.	Outline how to prescribe medication regimens that are proven safe and effective for HIV-negative patients who meet recommended screening criteria for PrEP initiation to reduce their risk of HIV acquisition. - Strongly disagree	Outline how to prescribe medication regimens that are proven safe and effective for HIV-negative patients who meet recommended screening criteria for PrEP initiation to reduce their risk of HIV acquisition. - Disagree	Outline how to prescribe medication regimens that are proven safe and effective for HIV-negative patients who meet recommended screening criteria for PrEP initiation to reduce their risk of HIV acquisition. - Slightly disagree	Outline how to prescribe medication regimens that are proven safe and effective for HIV-negative patients who meet recommended screening criteria for PrEP initiation to reduce their risk of HIV acquisition. - Neither	Outline how to prescribe medication regimens that are proven safe and effective for HIV-negative patients who meet recommended screening criteria for PrEP initiation to reduce their risk of HIV acquisition. - Slightly agree	Outline how to prescribe medication regimens that are proven safe and effective for HIV-negative patients who meet recommended screening criteria for PrEP initiation to reduce their risk of HIV acquisition. - Agree	Outline how to prescribe medication regimens that are proven safe and effective for HIV-negative patients who meet recommended screening criteria for PrEP initiation to reduce their risk of HIV acquisition. - Strongly agree
Educate providers about HIV PrEP medications, side effects, contraindications, and Food & Drug Administration (FDA)-approved regimens to maximize safe use.	Educate providers about HIV PrEP medications, side effects, contraindications, and Food & Drug Administration (FDA)-approved regimens to maximize safe use. - Strongly disagree	Educate providers about HIV PrEP medications, side effects, contraindications, and Food & Drug Administration (FDA)-approved regimens to maximize safe use. - Disagree	Educate providers about HIV PrEP medications, side effects, contraindications, and Food & Drug Administration (FDA)-approved regimens to maximize safe use. - Slightly disagree	Educate providers about HIV PrEP medications, side effects, contraindications, and Food & Drug Administration (FDA)-approved regimens to maximize safe use. - Neither	Educate providers about HIV PrEP medications, side effects, contraindications, and Food & Drug Administration (FDA)-approved regimens to maximize safe use. - Slightly agree	Educate providers about HIV PrEP medications, side effects, contraindications, and Food & Drug Administration (FDA)-approved regimens to maximize safe use. - Agree	Educate providers about HIV PrEP medications, side effects, contraindications, and Food & Drug Administration (FDA)-approved regimens to maximize safe use. - Strongly agree
Identify techniques to provide support for medication adherence to help patients achieve and maintain protective levels of medication in their bodies.	Identify techniques to provide support for medication adherence to help patients achieve and maintain protective levels of medication in their bodies. - Strongly disagree	Identify techniques to provide support for medication adherence to help patients achieve and maintain protective levels of medication in their bodies. - Disagree	Identify techniques to provide support for medication adherence to help patients achieve and maintain protective levels of medication in their bodies. - Slightly disagree	Identify techniques to provide support for medication adherence to help patients achieve and maintain protective levels of medication in their bodies. - Neither	Identify techniques to provide support for medication adherence to help patients achieve and maintain protective levels of medication in their bodies. - Slightly agree	Identify techniques to provide support for medication adherence to help patients achieve and maintain protective levels of medication in their bodies. - Agree	Identify techniques to provide support for medication adherence to help patients achieve and maintain protective levels of medication in their bodies. - Strongly agree
Describe HIV risk reduction techniques, prevention services, and/or infectious diseases specialist referral resources.	Describe HIV risk reduction techniques, prevention services, and/or infectious diseases specialist referral resources. - Strongly disagree	Describe HIV risk reduction techniques, prevention services, and/or infectious diseases specialist referral resources. - Disagree	Describe HIV risk reduction techniques, prevention services, and/or infectious diseases specialist referral resources. - Slightly disagree	Describe HIV risk reduction techniques, prevention services, and/or infectious diseases specialist referral resources. - Neither	Describe HIV risk reduction techniques, prevention services, and/or infectious diseases specialist referral resources. - Slightly agree	Describe HIV risk reduction techniques, prevention services, and/or infectious diseases specialist referral resources. - Agree	Describe HIV risk reduction techniques, prevention services, and/or infectious diseases specialist referral resources. - Strongly agree
Identify recommended schedule for monitoring patients to detect HIV infection, medication toxicities, and levels of risk behavior in order to make indicated changes in strategies to support patients’ long-term health	Identify recommended schedule for monitoring patients to detect HIV infection, medication toxicities, and levels of risk behavior in order to make indicated changes in strategies to support patients’ long-term health - Strongly disagree	Identify recommended schedule for monitoring patients to detect HIV infection, medication toxicities, and levels of risk behavior in order to make indicated changes in strategies to support patients’ long-term health - Disagree	Identify recommended schedule for monitoring patients to detect HIV infection, medication toxicities, and levels of risk behavior in order to make indicated changes in strategies to support patients’ long-term health - Slightly disagree	Identify recommended schedule for monitoring patients to detect HIV infection, medication toxicities, and levels of risk behavior in order to make indicated changes in strategies to support patients’ long-term health - Neither	Identify recommended schedule for monitoring patients to detect HIV infection, medication toxicities, and levels of risk behavior in order to make indicated changes in strategies to support patients’ long-term health - Slightly agree	Identify recommended schedule for monitoring patients to detect HIV infection, medication toxicities, and levels of risk behavior in order to make indicated changes in strategies to support patients’ long-term health - Agree	Identify recommended schedule for monitoring patients to detect HIV infection, medication toxicities, and levels of risk behavior in order to make indicated changes in strategies to support patients’ long-term health - Strongly agree

What do you anticipate changing or how will you apply what you learned in your professional practice? *

How will you apply what you learned when working with providers of other disciplines or members of your interprofessional healthcare team? *

What barriers, if any, do you see to implementing these changes? *

Please provide feedback on your experience navigating this website and completing the CE process. *

Based on your educational needs, what topics would you like to see addressed in future educational activities? *

Please discuss any additional concerns or comments about this program and indicate whether the program met your expectations. *

attestation checkbox *

I completed this educational activity independently and in its entirety.

Leave this field blank